Zhengye Biotechnology (NASDAQ:ZYBT) Stock Price Up 3.1% – Time to Buy?

Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) shares rose 3.1% on Tuesday . The stock traded as high as $0.8910 and last traded at $0.8910. Approximately 72,710 shares traded hands during mid-day trading, an increase of 97% from the average daily volume of 36,849 shares. The stock had previously closed at $0.8640.

Analysts Set New Price Targets

Separately, Weiss Ratings raised shares of Zhengye Biotechnology from a “sell (d-)” rating to a “sell (d)” rating in a research report on Friday, May 29th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock has an average rating of “Sell”.

Zhengye Biotechnology Stock Performance

The company has a debt-to-equity ratio of 0.03, a quick ratio of 0.82 and a current ratio of 1.14. The business’s 50-day moving average is $0.93 and its 200 day moving average is $1.14.

Zhengye Biotechnology (NASDAQ:ZYBT) last released its earnings results on Tuesday, April 28th. The company reported ($0.08) EPS for the quarter. The business had revenue of $3.97 million for the quarter.

Institutional Trading of Zhengye Biotechnology

A number of hedge funds and other institutional investors have recently modified their holdings of ZYBT. Citadel Advisors LLC acquired a new stake in Zhengye Biotechnology during the 3rd quarter worth approximately $31,000. Millennium Management LLC bought a new position in shares of Zhengye Biotechnology during the 3rd quarter worth approximately $38,000. WINTON GROUP Ltd bought a new position in Zhengye Biotechnology during the third quarter worth $56,000. XTX Topco Ltd boosted its stake in Zhengye Biotechnology by 71.4% during the fourth quarter. XTX Topco Ltd now owns 59,286 shares of the company’s stock worth $68,000 after acquiring an additional 24,697 shares in the last quarter. Finally, Geode Capital Management LLC acquired a new stake in Zhengye Biotechnology in the second quarter worth $174,000.

Zhengye Biotechnology Company Profile

Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer which encompasses research, development, manufacturing and sales of veterinary vaccines, with a focus on livestock vaccine principally in China. Zhengye Biotechnology Holding Limited is based in Jilin, China.